Steve DeVrieze, Vice President and Head of Emerging Biopharma and Technologies for Quintiles Commercial North America, is responsible for developing sales and market access solutions for emerging biopharma customers with pharmaceutical, medical devices or diagnostic products.
Since joining Quintiles in 2008, Steve has held a variety of increasingly senior roles within the company, primarily within the Commercial North America organization. Prior to his current role, Steve led the design and close of several multi-service commercial product launch partnerships for the emerging biopharma customer segment. Steve also has experience in evaluating risk-based transactions for small and mid-sized biopharma companies and conducting strategic assessments that developed into new Commercial North America offerings. Prior to joining Quintiles, Steve was a management consultant where he worked on systems integration and process re-engineering projects across several industries.
Steve graduated with a bachelor’s degree in business administration from Hope College in Holland, Mich., and received his master’s degree in business administration (MBA) from The Fuqua School of Business at Duke University with a concentration in health sector management.